Altman Michael Seth is a director of Nautilus Biotechnology Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Lyra Therapeutics, Inc.
5 Jul 23
4
Nautilus Biotechnology, Inc.
20 Jun 23
4
Lyra Therapeutics, Inc.
21 Jun 22
4
Nautilus Biotechnology, Inc.
17 Jun 22
4
ARYA Sciences Acquisition Corp V
15 Jul 21
3
ARYA Sciences Acquisition Corp V
12 Jul 21
4
Nautilus Biotechnology, Inc.
11 Jun 21
4
Lyra Therapeutics, Inc.
28 May 21
4
ARYA Sciences Acquisition Corp IV
2 Mar 21
3
ARYA Sciences Acquisition Corp IV
25 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | NAUT Nautilus Biotechnology | Stock Option Common Stock | Grant | Acquire A | No | No | 3.97 | 45,000 | 178.65 k | 45,000 |